AI
Wednesday, January 05, 2011 7:59:22 AM
Teva’s CFO said they estimate approval of generic Lovenox during 1Q11.
Which, IF TRUE, means the Wedbush writeup is unduly bullish.
Of course, this is at least the third incarnation of "when" TEVA expects approval.
ij
There are times when rules and precedents cannot be broken; others when they cannot be adhered to with safety. (Thomas Joplin)
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
